Seven patents currently held, every record listed here
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in May 2040. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
May 2040
Next term end
1
Patent families
When these terms end
Each bar runs from grant to computed term end. 2021 to 2040.
US 11,090,278
Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
May 16, 2040
US 11,464,752
Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
May 16, 2040
US 11,241,400
Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
May 16, 2040
US 11,426,369
Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
May 16, 2040
US 11,478,436
Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
no later than May 16, 2040
US 11,571,398
Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
no later than May 16, 2040
US 12,797,345
Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
May 16, 2040
20252029203320372040
A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.
Every computed term in this portfolio is shown above.Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 1 of the currently held patents qualifies as notable.
Fee deadlines
No maintenance fee falls due on this company's record before Nov 17, 2027.
Recent changes
- 1 of the patents on this record was granted since Aug 22, 2026
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Showing 1 to 7 of 7
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,090,278 | Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same In force · High confidence | In force | High confidence | |
| US 11,241,400 | Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same In force · High confidence | In force | High confidence | |
| US 11,426,369 | Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same In force · Medium confidence | In force | Medium confidence | |
| US 11,464,752 | Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same In force · High confidence | In force | High confidence | |
| US 11,478,436 | Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same In force · Medium confidence | In force | Medium confidence | |
| US 11,571,398 | Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same In force · Medium confidence | In force | Medium confidence | |
| US 12,797,345 | Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same In force · Medium confidence | In force | Medium confidence |
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
2 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed